pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4301 |
Genomic Coordinates | chr11: 113450023 - 113450088 |
Description | Homo sapiens miR-4301 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4301 | ||||||||||||||||||
Sequence | 11| UCCCACUACUUCACUUGUGA |30 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | SOLiD | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SLC31A1 | ||||||||||||||||||||
Synonyms | COPT1, CTR1 | ||||||||||||||||||||
Description | solute carrier family 31 member 1 | ||||||||||||||||||||
Transcript | NM_001859 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SLC31A1 | |||||||||||||||||||||
3'UTR of SLC31A1 (miRNA target sites are highlighted) |
>SLC31A1|NM_001859|3'UTR 1 CATCAAACTCTATGGCGTGGCCTTATCGATTGCAGTGGGAAGTTGTTGAAGACTTGAAGACGTGATTCCTGCTCCAATCA 81 TCCCTTCTTGCTCCTCTTTGTGCACGTACACACACACACACACACACACACACACACACCCCTGCTCAACAGAGGTTTAG 161 TTTACAGTCTCTGAACTAAAGTAGTAACCTCCCAAATTGTTTTTTCTAATAAGCTGAGATTCCCATTTCTCTTAAGGAGA 241 AGCCACCCATGAGATGTCTTTTCCTTCTCCATCATCTTAGAGCCAAGTTATATGTTCTTGTCTAATCCATGTAGCTTTTT 321 GTTCAATGACTTGATCATCTGCTTCCTTTTTGAATTTTTAACAGATAGTAAGTAAATTTGGTGGTTTTTTCCCCTGGGTC 401 AGTGATGGAAAGGGGTTAACTTCAGCCAGGATTGATGGCAGCTGAGGGAAATTCTTGCCCAACTAAACCCAGAACTCAAA 481 CTTAACATTAGAAAATAAGGTCCAGGGCCGGACACAGTGGCCCATGCCTGTAATCCCAGCACTTTGGGGGGCCAAGGCAG 561 GCTGGATCACCTGAGGACAGGAGTTCGAGACCAGTCTGGCCAACATGGGGAAACCCCGTCTCTACTAAAAATACAAAAAT 641 TAGCCGGGCATGGTGGTGGGCGCCTGTAATCCCAGCTACTCAGAAGGCTGAGGCAGGAGAATCACTTGAACCTAGGAGGC 721 GGAGGTTGCAGTGAGCCAAGATGGCGCCATTGCACTCCAGCCTGGGTGACAAGAGTGAAACTCCATCTCAAAAAAAAAGA 801 AAAGAAGGTCCAGCTTTTGGATTCAATGAGTGGGAAATACATTGTGCCTTTCTCTAGATGTGATACGTTATACCAAAATC 881 TTTGTAGTGTGCAGAGCGGTGGTTTGAGACTAAATACAGGCTTAGAACTTGCAGAGTGTGTATTCTTGGATGGCTGATGC 961 ATCGACTTGCATTCCCACTTAACACTTTGATTAGCATGAACTTGCCAATCAAAAAATGACAATCAATTTGAGAAAATAGA 1041 AATAGATATTTTTAAATAAAACCATTCACAGTTTACTTTGTCTTGATACCTTGGTTTGTCCCAGCTGAAGTGAAGCAAGA 1121 GAGTTTGAATTAATTTTTCCATTATAATGTTTTCGCATGTCTGCCTCTAAAACTGTGATTTTCAAGCTTTAGCGTGCATC 1201 AGAATCACCTGTAGGGCTTGTTAAAACACTAATTGCTGGGCCTCAACCCAAAAGCCCCCAAAGTGGCACTTCTGAGTTCC 1281 TGCTGATGTTACAAGGGACCACACTTTTGAGAATCTGTGCTTTAAGCTAAGGAAATATTGCCTGGTGGGTTGGCTGCCTG 1361 GTATTGGGCATGGAAATTTGAATTGCTGATTGGTAGATGGTGTGTCTGGACTTAACTCACGTAGTAAATACTGCTGATCA 1441 ATACCTAATCATTCCACATTTATTGAGCTCCACCTGTGTGTATGTGTACCCAAGCACACATGTGTGAAGGGCTATAGCCA 1521 AAGTATTTTTACTAGCCTGTATGAAATCACTAGTCCTTATTTTTAAAGGTCTATGGTTTCTTGGAAGTAGTTTGATTGTT 1601 GAGAGAGACCTTTGATCTGCAGTGTAAATCTACCAGTCATGGGCCAGAAGGGCAAAAGCCCAGCTTTCTCTTTGGAAAGA 1681 CTCAGGCTGTGGTTTGTTGATGGCCAGGTTTTCCTCAGGCTCCAACAACTGTGCTTATACCAAGCAGATCCTCATCCTCC 1761 ATATAATCATCTTTGTTATTCGTGGGGGTTTAATTACATTACAAGTGGCCAAAACCCCTGTTCTCAGTGAAGAACCACAT 1841 TGGATTTGTATTCTGTTCAGTTGTAGTCTACACTGCAGTCTTATTCCTGGTTCAAACTACCTCTTTAAATTGATTTGTCT 1921 TGTGCTGGTCTGTTAAATCCTGCCCTCCTTGGTGCTAGATCCAGTTGTGCCTCAGGGCAGAGGAAACAAAACACAGCTAT 2001 CCTGTTGGCCTGTGTTGTGGTTTTGAAGTTTGTACTTTCTCTGTGGGTGCCAGTTAAATATTGGAGAGCAAGGAATGTGG 2081 ACTTGTATGGCTTTGAACCAAGAGAGGGTTATGAGCCTACTGGATTGAGGTTAAAATCCAAGAACCAACATTTAGAGCTT 2161 TGTGCTTTTCTCTCATTCCATCACTTTGTAATGATGATACTTAACATGAGCAGGGTGAATGACAGGTACTGACGAAGTCC 2241 AACACAAAGGTATAATACAGCCTGTTGTCTAAAGCCAAGGAGTCATAAAACCATGAGAAATAAATAGGAATCAATAGTTA 2321 GTAGTGACATTGGTGCTCTCTAGAAATCTCAGCATGAGCTGCTATAGAATACCCTCCCAGCAACAAAACCTAATCAGTAA 2401 GGCCAGCTAGACCCAATGGCTCATGCCTGTAATCCCAACACTTTGGGAGGCCAAGGTGGGAGGATGGCTTGTGTCCAGAA 2481 GTTCGAGACCAGCCTGGACAACATAGTGAGATCCTATCTCTATAAAAAATCAAAAATTAGCCAGGCATGGTGGTGCATAC 2561 CTATAGTCCTGGCTATTTGGGAGGCTGAGGCAGGAGGATTGCTTTAGCCCTGGAGGTCGAGGCTGCAGTAAGCCATGATT 2641 GCGCCACTGCACTCAGCCCGGGTGACAAAGCAAGACCCTGTCTCAGAAAAAAAGAAAATTCAAGGCCAGTTAAGACAAAA 2721 TGCTATGACTTTGAAATTCACAGAAAGAAATAACAGTTTAGATTAGGTCTTCAGGTATTCAGGATAGAGATAATCTCCTG 2801 AAAAACCTGAATTTCAGAGATTCTTAGACTGGCTGCCAAAGGATGAAGCTAGTGAAGGAGAAAAAGCTTAAATTCCATCT 2881 TGAGCTCTTGGATTGTGATAATACAATGATTTCATTAACTTTTCATTTCTGTATACCTGTTCATTTGGAATTTAATGCTT 2961 GACTTCTTTGTTCATTTTGGATCTAAACTTCTCTTTTCTTCCTTCCCCATTCACATCTATTAGAAGACTGCATCACCATT 3041 TCTTTGGCCCCCTTACTCTGTTGTCCTTTCCCTTTTCTTTCAGTTTTTTTAATCGCATGTCTAGTATATTAAGTCTCCAT 3121 AGCCCTCCTGATGCAGTAGACAGTGCTATGCTGTGGATATAATACCAACCAGAAATTGGCATTTATAAACCTGTTAAGAG 3201 ACTTTAAGCATGCTTCAAGAGGCAGTTGACCCACTGGAATTTCTATAAGGCTGGTACCCTTCCCAGAGTTACAGAATCTT 3281 AGGTGCCGTCTCTAGTCTGTGAGGGAGGAACTCCCAGCATCCCCATTGCCCACAAATGGAATCCTCACTGTATCCACTAG 3361 GAGATTAGAAATTAAGGTTTCTTCACTACTTCTATGGTAGGGTTGTCTGAAATTCCCTTTCAGGCTGTGGGTACTGGTCT 3441 TGGGTTCTAGTCATAAGGGGTTCCTTATAAGGAGCAGGCGGAGGGGAGTACACTTTCATGTGATTTAATTTTGATCCTGC 3521 CCTCTCCAGCTGCTCCTTCAAAAGATACATCAAAAGATAGAAACTCTGGGCTGGGCACAGTGGCTCACACACTTTGGGAG 3601 GCCAAGCGGGGGTGCAGATCACCTGAGGTCAGGAGTTTGAGACCAGCCTGGCCAATGTGGTGAAACCCCATCTCTACTAA 3681 AAATACAAAAATTAGCTGGGCGTGGTGGTGCATGCCTGTAATCCCAGCTACTCGGGAGGCTGAGGCAGGAGAATCGCTTG 3761 AACCCAGGAGGCGGAGGTTGCAGTGAGCCAAGATGGCGCCATTGCACTCCAGCCTGGGCGACAAGAGCAAAACTCCGTCT 3841 CAAAAAAAAAAAAAAGATACAAAGTCTGCATTTGATATAATGCCTTAATTACTGGGTCTACAATTAATGTTGACTGTTTT 3921 AGATTGTAAGCTCCTGGAGAGCAGTATTGCTGTAGTAGGAATGTTTTAACAGTGTCATATGAAAAAGAACAAAATAAATA 4001 TTTTGATTTTGTGATTCTAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
CLIP-seq Support 1 for dataset GSM4903825 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID14_NS |
Location of target site | NM_001859 | 3UTR | AUCGAUUGCAGUGGGAAGUUGUUGAAGACUUGAAGACGUGAUUCCUGCUCCAAUCAUCCCUUCUUGCUCCUCUUUGUGCACGUACACACACAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000374212.4 | 3UTR | AUUCAAUGAGUGGGAAAUACAUUGUGCCUUUCUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
83 hsa-miR-4301 Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT081134 | LDLR | low density lipoprotein receptor | ![]() |
![]() |
2 | 4 | ||||||
MIRT090911 | ARHGEF26 | Rho guanine nucleotide exchange factor 26 | ![]() |
![]() |
2 | 2 | ||||||
MIRT229436 | MECP2 | methyl-CpG binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT274717 | CPSF6 | cleavage and polyadenylation specific factor 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT350957 | BACH1 | BTB domain and CNC homolog 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT386722 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT446022 | PEX3 | peroxisomal biogenesis factor 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT481303 | ATP5G3 | ATP synthase, H+ transporting, mitochondrial Fo complex subunit C3 (subunit 9) | ![]() |
![]() |
2 | 14 | ||||||
MIRT483959 | ZNF354B | zinc finger protein 354B | ![]() |
![]() |
2 | 6 | ||||||
MIRT495667 | TUBAL3 | tubulin alpha like 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT496554 | TBX15 | T-box 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT497702 | ARL6IP6 | ADP ribosylation factor like GTPase 6 interacting protein 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT498105 | RMND5A | required for meiotic nuclear division 5 homolog A | ![]() |
![]() |
2 | 2 | ||||||
MIRT512535 | SEMA4D | semaphorin 4D | ![]() |
![]() |
2 | 2 | ||||||
MIRT512556 | MFN2 | mitofusin 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT521465 | RABGAP1 | RAB GTPase activating protein 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT526236 | C2orf15 | chromosome 2 open reading frame 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT526743 | HLA-DOB | major histocompatibility complex, class II, DO beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT527578 | BRD7 | bromodomain containing 7 | ![]() |
![]() |
2 | 4 | ||||||
MIRT528038 | WT1 | Wilms tumor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT528267 | GPRIN2 | G protein regulated inducer of neurite outgrowth 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT528505 | HTR7 | 5-hydroxytryptamine receptor 7 | ![]() |
![]() |
2 | 4 | ||||||
MIRT528758 | RPS27 | ribosomal protein S27 | ![]() |
![]() |
2 | 6 | ||||||
MIRT528999 | IPO9 | importin 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT529701 | MRPL30 | mitochondrial ribosomal protein L30 | ![]() |
![]() |
2 | 2 | ||||||
MIRT529781 | C17orf82 | chromosome 17 open reading frame 82 | ![]() |
![]() |
2 | 2 | ||||||
MIRT533797 | TMEM119 | transmembrane protein 119 | ![]() |
![]() |
2 | 6 | ||||||
MIRT535308 | PHF12 | PHD finger protein 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT535917 | MKL2 | MKL1/myocardin like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT544892 | OSBPL1A | oxysterol binding protein like 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT555423 | PPIC | peptidylprolyl isomerase C | ![]() |
![]() |
2 | 2 | ||||||
MIRT562068 | KLHL15 | kelch like family member 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565623 | SLC31A1 | solute carrier family 31 member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565661 | SIX1 | SIX homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570138 | IL1RL2 | interleukin 1 receptor like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT571045 | YRDC | yrdC N6-threonylcarbamoyltransferase domain containing | ![]() |
![]() |
2 | 2 | ||||||
MIRT621232 | LMAN1 | lectin, mannose binding 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT622272 | SH3TC2 | SH3 domain and tetratricopeptide repeats 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT623844 | GAN | gigaxonin | ![]() |
![]() |
2 | 2 | ||||||
MIRT626158 | NFYA | nuclear transcription factor Y subunit alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT626464 | CMKLR1 | chemerin chemokine-like receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT632087 | ALDH1A2 | aldehyde dehydrogenase 1 family member A2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT637243 | FAM26E | calcium homeostasis modulator family member 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT642710 | FGFR1OP2 | FGFR1 oncogene partner 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT643611 | KANSL3 | KAT8 regulatory NSL complex subunit 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT644270 | PAFAH1B1 | platelet activating factor acetylhydrolase 1b regulatory subunit 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT645470 | SPIN3 | spindlin family member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT649193 | DNPEP | aspartyl aminopeptidase | ![]() |
![]() |
2 | 2 | ||||||
MIRT650776 | POP4 | POP4 homolog, ribonuclease P/MRP subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT651345 | ZC2HC1C | zinc finger C2HC-type containing 1C | ![]() |
![]() |
2 | 2 | ||||||
MIRT652237 | TRAPPC3L | trafficking protein particle complex 3 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT652587 | TIMM8A | translocase of inner mitochondrial membrane 8A | ![]() |
![]() |
2 | 2 | ||||||
MIRT654591 | PURA | purine rich element binding protein A | ![]() |
![]() |
2 | 2 | ||||||
MIRT654649 | PTAFR | platelet activating factor receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT656842 | KLF7 | Kruppel like factor 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT657209 | IKZF2 | IKAROS family zinc finger 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT658513 | ETV3 | ETS variant 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT659448 | CNNM2 | cyclin and CBS domain divalent metal cation transport mediator 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT668816 | CYLD | CYLD lysine 63 deubiquitinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT669067 | CELSR3 | cadherin EGF LAG seven-pass G-type receptor 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT677711 | ELOF1 | elongation factor 1 homolog | ![]() |
![]() |
2 | 4 | ||||||
MIRT687146 | PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT698498 | THOC2 | THO complex 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT707930 | PPP1R3D | protein phosphatase 1 regulatory subunit 3D | ![]() |
![]() |
![]() |
![]() |
4 | 2 | ||||
MIRT708737 | FAM71F2 | family with sequence similarity 71 member F2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT710031 | POLL | DNA polymerase lambda | ![]() |
![]() |
2 | 2 | ||||||
MIRT712175 | STK4 | serine/threonine kinase 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT715297 | MAPK1 | mitogen-activated protein kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT716892 | AGPAT6 | glycerol-3-phosphate acyltransferase 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT717378 | RBM41 | RNA binding motif protein 41 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718082 | CLIC5 | chloride intracellular channel 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718721 | ANKRD18A | ankyrin repeat domain 18A | ![]() |
![]() |
2 | 2 | ||||||
MIRT719152 | DPYSL5 | dihydropyrimidinase like 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT719224 | CAMK4 | calcium/calmodulin dependent protein kinase IV | ![]() |
![]() |
2 | 2 | ||||||
MIRT719528 | SRCIN1 | SRC kinase signaling inhibitor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT719861 | KLF2 | Kruppel like factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT720326 | CAMK2G | calcium/calmodulin dependent protein kinase II gamma | ![]() |
![]() |
2 | 2 | ||||||
MIRT721596 | SREBF1 | sterol regulatory element binding transcription factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT722020 | NEBL | nebulette | ![]() |
![]() |
2 | 2 | ||||||
MIRT722484 | QSOX1 | quiescin sulfhydryl oxidase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT722614 | TEAD1 | TEA domain transcription factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT723664 | RPTN | repetin | ![]() |
![]() |
2 | 2 | ||||||
MIRT723939 | SVOP | SV2 related protein | ![]() |
![]() |
2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|